GRDN (Guardian Pharmacy Services) Stock Based Compensation: $12 Mil (TTM As of Mar. 2026)


GRDN Guardian Pharmacy Services Inc GRDN
42 GF Score
Price $40.96
! 4 Warning Signs
View Full Analysis

What is Guardian Pharmacy Services Stock Based Compensation?

Guardian Pharmacy Services GRDN -0.24% 42 Stock Based Compensation is $12 Mil as of Mar. 2026. GuruFocus rates GRDN with a GF Score™ of 42/100. The stock has 4 warning signs investors should review.

Guardian Pharmacy Services's Stock Based Compensation for the three months ended in Mar. 2026 was $2 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was $12 Mil.

Guardian Pharmacy Services Stock Based Compensation Related Terms

Guardian Pharmacy Services Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Guardian Pharmacy Services's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guardian Pharmacy Services Stock Based Compensation Chart

Guardian Pharmacy Services Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial 13.03 -3.38 -6.09 131.49 13.85

Guardian Pharmacy Services Quarterly Data
Dec20 Mar21 Sep21 Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.97 4.45 4.36 1.08 1.86
GRDN
42GF Score
Guardian Pharmacy Services Inc GRDN
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guardian Pharmacy Services Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $12 Mil.

What does a Stock Based Compensation of $12 Mil mean?
Guardian Pharmacy Services (GRDN) has a Stock Based Compensation of $12 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Guardian Pharmacy Services and its competitors.
Is Guardian Pharmacy Services' Stock Based Compensation too high?
Guardian Pharmacy Services' current Stock Based Compensation is $12 Mil. Overall, Guardian Pharmacy Services has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Guardian Pharmacy Services' Stock Based Compensation compare to ACHC and ASTH?
Guardian Pharmacy Services' Stock Based Compensation of $12 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Healthcare Providers & Services company?
A good Stock Based Compensation depends on the Healthcare Providers & Services industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Guardian Pharmacy Services and its competitors. Guardian Pharmacy Services's current Stock Based Compensation is $12 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guardian Pharmacy Services stock overvalued right now?
Guardian Pharmacy Services (GRDN) has a current Stock Based Compensation of $12 Mil. The current Stock Based Compensation is $12 Mil. Guardian Pharmacy Services' overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Guardian Pharmacy Services (GRDN), the current Stock Based Compensation is $12 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Guardian Pharmacy Services Business Description

Address 300 Galleria Parkway SE, Suite 800, Atlanta, GA, USA, 30339
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.
42GF Score

Get the complete analysis for GRDN

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$40.96
Price